Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $6.89 Million - $7.71 Million
-81,722 Reduced 21.62%
296,275 $27.4 Million
Q1 2024

May 15, 2024

BUY
$72.54 - $95.56 $27.4 Million - $36.1 Million
377,997 New
377,997 $36.1 Million
Q2 2023

Aug 14, 2023

BUY
$81.41 - $94.33 $2.11 Million - $2.45 Million
25,962 Added 3090.71%
26,802 $2.53 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $267,336 - $304,236
-3,600 Reduced 81.08%
840 $69,000
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $57.1 Million - $73.1 Million
-835,440 Reduced 99.47%
4,440 $331,000
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $50.6 Million - $65.9 Million
-614,422 Reduced 42.25%
839,880 $69.4 Million
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $24.5 Million - $36.3 Million
283,024 Added 24.16%
1,454,302 $138 Million
Q1 2022

May 16, 2022

BUY
$101.96 - $128.34 $37.8 Million - $47.6 Million
370,887 Added 46.34%
1,171,278 $138 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $78.1 Million - $95.9 Million
733,840 Added 1102.67%
800,391 $104 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $1.53 Million - $1.82 Million
14,840 Added 28.7%
66,551 $7.53 Million
Q2 2021

Aug 16, 2021

SELL
$83.84 - $104.76 $167,847 - $209,729
-2,002 Reduced 3.73%
51,711 $5.36 Million
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $554,457 - $638,951
7,047 Added 15.1%
53,713 $4.49 Million
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $82,300 - $104,732
-1,148 Reduced 2.4%
46,666 $4.26 Million
Q3 2020

Nov 13, 2020

BUY
$67.19 - $87.44 $2.06 Million - $2.69 Million
30,719 Added 179.7%
47,814 $3.82 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $366,875 - $490,633
6,376 Added 59.48%
17,095 $1.18 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $56,026 - $86,589
-1,069 Reduced 9.07%
10,719 $2.02 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $731,340 - $837,318
10,200 Added 642.32%
11,788 $2.75 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $182,988 - $224,253
-2,973 Reduced 65.18%
1,588 $349,000
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $23.8 Million - $27.5 Million
-427,319 Reduced 98.94%
4,561 $843,000
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $20.7 Million - $27.7 Million
431,880 New
431,880 $82.6 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $94,954 - $116,499
-2,046 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $1.64 Million - $2.08 Million
-35,878 Reduced 94.6%
2,046 $356,000
Q2 2018

Jul 19, 2018

SELL
$42.45 - $51.3 $233,687 - $282,406
-5,505 Reduced 12.68%
37,924 $5.52 Million
Q1 2018

May 10, 2018

SELL
$37.19 - $47.45 $4.06 Million - $5.18 Million
-109,099 Reduced 71.53%
43,429 $6.06 Million
Q4 2017

Feb 14, 2018

BUY
$33.79 - $39.39 $4.43 Million - $5.16 Million
131,053 Added 610.26%
152,528 $17.2 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $779,327 - $833,874
21,475
21,475 $2.35 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.